Sildenafil, a phosphodiesterase type 5 inhibitor, augments sphincter bursting and bladder afferent activity to enhance storage function and voiding efficiency in mice. (17th February 2019)

• Record Type: Journal Article
• Authors: Ito, Hiroki; Chakrabarty, Basu; Drake, Marcus J.; Fry, Christopher H.; Kanai, Anthony J.; Pickering, Anthony E.
• Is Part Of: BJU international. Volume 124:Number 1(2019)
• Page Start: 163
• Page End: 173
• Publication Date: 2019-02-17
• Subjects: phosphodiesterase type 5 -- Sildenafil -- lower urinary tract -- external sphincter function -- mice; Genitourinary organs -- Diseases -- Periodicals; Genitourinary organs -- Surgery -- Periodicals; Urology -- Periodicals; 616.6
• DOI: 10.1111/bju.14664
• Languages: English
• ISSNs: 1464-4096

Abstract

Abstract : Objectives: To investigate the influence of low‐dose sildenafil, a phosphodiesterase type 5 inhibitor (PDE5‐I), on the function of the mouse lower urinary tract (LUT). Materials and Methods: Adult male mice were decerebrated and arterially perfused with a carbogenated Ringer's solution to establish the decerebrate arterially perfused mouse (DAPM). To allow distinction between central neural and peripheral actions of sildenafil, experiments were conducted in both the DAPM and in a 'pithed' DAPM, which has no functional brainstem or spinal cord. The action of systemic and intrathecal sildenafil on micturition was assessed in urethane‐anaesthetised mice. Results: In the DAPM, systemic perfusion of sildenafil (30 pm ) decreased the voiding threshold pressure [to a mean (sem ) 84.7 (3.8)% of control] and increased bladder compliance [to a mean (sem ) 140.2 (8.3)% of control, an effect replicated in the pithed DAPM]. Sildenafil was without effect on most voiding variables but significantly increased the number of bursts of the external urethral sphincter (EUS) per void in DAPM [to a mean (sem ) 130.1 (6.9)% of control at 30 pm] and in urethane‐anaesthetised mice [to a mean (sem ) 117.5 (5.8)% of control at 14 ng/kg]. Sildenafil (10 and 30 pm ) increased pelvic afferent activity during both bladder filling and the isovolumetric phase [to a mean (sem ) 205.4 (30.2)% of control at 30 pm] . Intrathecal application of sildenafil (5 μL of either 150 pm or 1.5 nm ) did not alter cystometry and EUS‐electromyography variables in urethane‐anaesthetised mice. Conclusions: Low‐dose sildenafil increases bladder compliance, increases pelvic nerve afferent activity, and augments the bursting activity of the EUS. We propose that the novel actions on afferent traffic and sphincter control may contribute to its beneficial actions to restore storage and voiding efficiency in LUT dysfunction.